Skip to main content

Table 1 Evaluation of the behaviour of TNHs nanoconstructs in biological media

From: Nanotechnological engineering of extracellular vesicles for the development of actively targeted hybrid nanodevices

Stability in cell culture medium

Time

(a) Mean size (nm)

(b) Concentration (part/mL)

(c) Percentage decrease (as percentage) from initial t0 value

%co-ZnO

Medium

TNHs

Medium

TNHs

t0

86 ± 4

128 ± 8

3.88 × 109 ± 3.44 × 108

3.96 × 109 ± 5.57 × 108

–

1 h

79 ± 5

144 ± 4

5.18 × 109 ± 1.05 × 108

6.42 × 109 ± 4.25 × 108

− 17 ± 3%

24 h

78 ± 6

138 ± 3

3.60 × 109 ± 1.50 × 108

7.52 × 109 ± 1.40 × 109

− 20 ± 4%

48 h

83 ± 4

135 ± 13

4.60 × 109 ± 7.73 × 108

5.66 × 109 ± 1.23 × 109

− 15 ± 10%

(d) Clotting time in human recovered plasma

 

Ctrl (plasma)

Plasma + Phys. solution

Plasma + Phys. solution + water

Plasma + Phys. solution + water and TNHs

Time (min)

10.3 ± 0.3

10.4 ± 0.3

10.7 ± 0.5

9.5 ± 0.6

  1. (a) Mean size and (b) concentration of TNHs assessed through Nanoparticles Tracking Analysis at t0 and after 1, 24 and 48 h incubation at 37 °C in cell culture medium. (c) Estimation of the coupling efficiency after 1, 24 and 48 h incubation at 37 °C in cell culture medium expressed as percentage decrease of %co-ZnO with respect to t0. (d) Plasma clotting time measurements following the incubation with TNHs. The values for plasma alone, plasma/physiological solution, plasma/bd water and physiological solution 1:1 (v/v) are reported as controls. All experiments were conducted at least in duplicate